SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-012910
Filing Date
2021-05-26
Accepted
2021-05-26 07:10:25
Documents
13
Period of Report
2021-05-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38266
2 ex99-1.htm EX-99.1 86527
  Complete submission text file 0001493152-21-012910.txt   319828

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abeo-20210525.xsd EX-101.SCH 3053
4 XBRL LABEL FILE abeo-20210525_lab.xml EX-101.LAB 34238
5 XBRL PRESENTATION FILE abeo-20210525_pre.xml EX-101.PRE 22377
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3607
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 21962721
SIC: 2834 Pharmaceutical Preparations